Fetuin A test to predict kidney function decline
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a blood protein called fetuin A to see if it can forecast worsening kidney function over time in people with treated high blood pressure. It may help identify who is at higher risk for kidney decline so care can be adjusted earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high blood pressure and are taking at least one blood pressure medicine
- You do not have diabetes (including based on recent blood sugar or HbA1c results)
- Your blood pressure is not very uncontrolled (not around 180/110 or higher in clinic or on 24-hour monitoring)
- You are not on dialysis or any kidney replacement therapy
- You do not currently have active severe illness from the listed conditions, such as ongoing acute infection
- You do not have major liver disease or a terminal, incurable illness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood markers (biomarkers) relate to kidney function decline in people with pulmonary hypertension. Participants will have blood and urine tests, and their kidney function will be tracked over time.
This study looks at blood samples from people with kidney problems to learn more about the condition and find better ways to treat it.
This study looks for new markers in blood or urine that may help explain heart (cardiovascular) risk in people with chronic kidney disease. It may help doctors better predict risk, especially in those not yet on dialysis.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
This study looks at FGF19 to see if it can improve chronic kidney disease in people who do not have diabetes. Participants may receive FGF19 (and may need extra testing such as muscle biopsies).
This study looks at whether simple blood test results (levels of certain white blood cells and platelets) can help predict how quickly chronic kidney disease may get worse. If you join, researchers will track your kidney function over time to see if these blood levels are linked to faster progression.
Hear when a new Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.